Corporate ActionJul 1, 2026, 07:21 AM
Inmune Bio Induces Warrant Exercise, Extends Maturity, Raises $905K
AI Summary
Inmune Bio, Inc. announced a warrant inducement offer to holders of its April 2024 Warrants. The offer allows holders to exercise 50% of their warrants at a reduced price of $1.40 per share, down from $1.95. In exchange, the maturity date for the remaining 50% of the warrants will be extended from June 30, 2026, to December 31, 2027. The company expects to receive approximately $905,957 from the exercise of 647,112 warrants.
Key Highlights
- Inmune Bio entered into a warrant inducement offer letter and an amendment to common stock purchase warrant.
- Holders were offered to exercise 50% of April 2024 Warrants at a reduced price of $1.40 per share (from $1.95).
- Maturity date for the remaining 50% of April 2024 Warrants extended from June 30, 2026, to December 31, 2027.
- Holders agreed to exercise 647,112 April 2024 Warrants.
- Company expects to receive an aggregate of $905,957 from the exercise of these warrants.
Price Impact
More from INMB